Insurer Brain

AXA/2025/FY/Financial supplement: Difference between revisions

Browse history interactively
← Older editNewer edit →
Content deleted Content added
VisualWikitext
doc_archive: publish gr2rpazfcv (.md link)
doc_archive: publish gr2rpazfcv
Line 9:
| language = English
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_KkMFoBIGEg14b_AXA_Financial_Supplement_2025_synthesis.xlsx
| archive_file = File:AXA<!-2025-FY ARCHIVE_MD_LINK_HERE -Financial_supplement.md->
| intro_sentence = This article presents AXA's FY 2025 financial supplement — the detailed data tables behind the period's results.
}}
Line 1,841:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.4%
Line 1,863:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Undiscounted Current Accident Year Nat Cats
| style="text-align:right" | 3.6%
| style="text-align:right" | 3.8%
Line 1,885:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Current Accident Year Discounting
| style="text-align:right" | -3.9%
| style="text-align:right" | -3.6%
Line 2,105:
| style="text-align:right" | -20
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Investment Income
| style="text-align:right" | 1,967
| style="text-align:right" | 3,731
Line 2,127:
| style="text-align:right" | -20
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Insurance Finance Expenses
| style="text-align:right" | -643
| style="text-align:right" | -1,172
Line 2,347:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA
| style="text-align:right" | 0
| style="text-align:right" | 0
Line 2,369:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Non VFA
| style="text-align:right" | 113,515
| style="text-align:right" | 118,104
Line 2,593:
| style="text-align:right" | 44.6%
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.4%
Line 2,623:
| style="text-align:right" | 44.5%
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Undiscounted Current Accident Year Nat Cats
| style="text-align:right" | 3.6%
| style="text-align:right" | 3.8%
Line 2,653:
| style="text-align:right" | 1.2%
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Current Accident Year Discounting
| style="text-align:right" | -3.9%
| style="text-align:right" | -3.6%
Line 3,501:
| style="text-align:right" | 38
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Actual vs. Expected Cash Flows
| style="text-align:right" | 9
| style="text-align:right" | -15
Line 3,519:
| style="text-align:right" | -8
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Risk Adjustment Release
| style="text-align:right" | 30
| style="text-align:right" | 59
Line 3,537:
| style="text-align:right" | 8
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Changes in Onerous Contracts
| style="text-align:right" | -32
| style="text-align:right" | 6
Line 3,555:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Long-term
| style="text-align:right" | -72
| style="text-align:right" | -145
Line 3,609:
| style="text-align:right" | 175
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Investment Income
| style="text-align:right" | 1,319
| style="text-align:right" | 2,525
Line 3,627:
| style="text-align:right" | 456
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Insurance Finance Expenses
| style="text-align:right" | -783
| style="text-align:right" | -1,551
Line 3,807:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA
| style="text-align:right" | 234,783
| style="text-align:right" | 230,205
Line 3,825:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Non VFA
| style="text-align:right" | 94,677
| style="text-align:right" | 114,803
Line 3,933:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA Gross of reinsurance
| style="text-align:right" | 264,013
| style="text-align:right" | 273,094
Line 3,951:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w BBA Gross of reinsurance
| style="text-align:right" | 50,097
| style="text-align:right" | 51,845
Line 3,969:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Reinsurance
| style="text-align:right" | -18,768
| style="text-align:right" | -18,690
Line 4,211:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Actual vs. Expected Cash Flows
| style="text-align:right" | 9
| style="text-align:right" | -15
Line 4,237:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Risk Adjustment Release
| style="text-align:right" | 30
| style="text-align:right" | 59
Line 4,263:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Changes in Onerous Contracts
| style="text-align:right" | -32
| style="text-align:right" | 6
Line 4,289:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Long-term
| style="text-align:right" | -72
| style="text-align:right" | -145
Line 4,367:
| style="text-align:right" | 2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Investment Income
| style="text-align:right" | 1,319
| style="text-align:right" | 2,525
Line 4,393:
| style="text-align:right" | 2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Insurance Finance Expenses
| style="text-align:right" | -783
| style="text-align:right" | -1,551
Line 4,757:
| style="text-align:right" | '''0'''
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA Gross of reinsurance
| style="text-align:right" | 264,013
| style="text-align:right" | 273,094
Line 4,783:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w BBA Gross of reinsurance
| style="text-align:right" | 50,097
| style="text-align:right" | 51,845
Line 4,809:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Reinsurance
| style="text-align:right" | -18,768
| style="text-align:right" | -18,690
Line 5,059:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Actual vs. Expected Cash Flows
| style="text-align:right" | -4
| style="text-align:right" | -33
Line 5,085:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Risk Adjustment Release
| style="text-align:right" | 25
| style="text-align:right" | 51
Line 5,111:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Changes in Onerous Contracts
| style="text-align:right" | -30
| style="text-align:right" | 9
Line 5,137:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Long-term
| style="text-align:right" | -63
| style="text-align:right" | -124
Line 5,215:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Investment Income
| style="text-align:right" | 1,159
| style="text-align:right" | 2,209
Line 5,241:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Insurance Finance Expenses
| style="text-align:right" | -705
| style="text-align:right" | -1,410
Line 5,605:
| style="text-align:right" | '''0'''
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA Gross of reinsurance
| style="text-align:right" | 243,037
| style="text-align:right" | 251,273
Line 5,631:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w BBA Gross of reinsurance
| style="text-align:right" | 50,917
| style="text-align:right" | 52,713
Line 5,657:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Reinsurance
| style="text-align:right" | -18,679
| style="text-align:right" | -18,595
Line 5,907:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Actual vs. Expected Cash Flows
| style="text-align:right" | 13
| style="text-align:right" | 18
Line 5,933:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Risk Adjustment Release
| style="text-align:right" | 4
| style="text-align:right" | 8
Line 5,959:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Changes in Onerous Contracts
| style="text-align:right" | -1
| style="text-align:right" | -2
Line 5,985:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Long-term
| style="text-align:right" | -8
| style="text-align:right" | -21
Line 6,063:
| style="text-align:right" | 2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Investment Income
| style="text-align:right" | 160
| style="text-align:right" | 317
Line 6,089:
| style="text-align:right" | 2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Insurance Finance Expenses
| style="text-align:right" | -78
| style="text-align:right" | -140
Line 6,453:
| style="text-align:right" | '''0'''
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w VFA Gross of reinsurance
| style="text-align:right" | 20,977
| style="text-align:right" | 21,821
Line 6,479:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w BBA Gross of reinsurance
| style="text-align:right" | -821
| style="text-align:right" | -868
Line 6,505:
| style="text-align:right" | 0
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | o/w Reinsurance
| style="text-align:right" | -90
| style="text-align:right" | -95
Line 6,615:
| style="text-align:right" | '''341'''
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Alternatives
| style="text-align:right" | 227
| style="text-align:right" | 86
Line 6,625:
| style="text-align:right" | 95
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Core & Other
| style="text-align:right" | 532
| style="text-align:right" | 254
Line 6,635:
| style="text-align:right" | 246
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Asian Joint Ventures
| style="text-align:right" | 101
| style="text-align:right" | —
Line 6,665:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Management Fees
| style="text-align:right" | 679
| style="text-align:right" | 385
Line 6,675:
| style="text-align:right" | 439
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Performance Fees
| style="text-align:right" | 18
| style="text-align:right" | 8
Line 6,685:
| style="text-align:right" | 9
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Distribution Fees
| style="text-align:right" | 205
| style="text-align:right" | —
Line 6,695:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other
| style="text-align:right" | 35
| style="text-align:right" | —
Line 6,715:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Distribution Fees Retroceded
| style="text-align:right" | -205
| style="text-align:right" | —
Line 6,907:
| style="text-align:right" | 7.5
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Property & Casualty
| style="text-align:right" | —
| style="text-align:right" | 4.0
Line 6,913:
| style="text-align:right" | 5.1
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Life & Health
| style="text-align:right" | —
| style="text-align:right" | 3.6
Line 6,919:
| style="text-align:right" | 2.5
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Asset Management & Other
| style="text-align:right" | —
| style="text-align:right" | 0.1
Line 7,083:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | New Business Contractual Service Margin (NB CSM)
| style="text-align:right" | 1,131
| style="text-align:right" | —
Line 7,117:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other NBV {{footnote|1=Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.}}
| style="text-align:right" | 456
| style="text-align:right" | —
Line 7,151:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Tax
| style="text-align:right" | -381
| style="text-align:right" | —
Line 7,355:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | New Business Contractual Service Margin (NB CSM)
| style="text-align:right" | 1,131
| style="text-align:right" | 203
Line 7,385:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other NBV {{footnote|1=Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.}}
| style="text-align:right" | 456
| style="text-align:right" | 275
Line 7,415:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Tax
| style="text-align:right" | -381
| style="text-align:right" | -123
Line 7,557:
| style="text-align:right" | 23.9
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Present Value of Future Cash Flows
| style="text-align:right" | 24.1
| style="text-align:right" | 22.0
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Contractual Service Margin
| style="text-align:right" | 1.4
| style="text-align:right" | 1.4
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Risk Adjustment
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
Line 7,615:
| style="text-align:right" | 470.4
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Present Value of Future Cash Flows
| style="text-align:right" | 438.4
| style="text-align:right" | 432.6
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Contractual Service Margin
| style="text-align:right" | 35.3
| style="text-align:right" | 34.7
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Risk Adjustment
| style="text-align:right" | 3.3
| style="text-align:right" | 3.1
Line 7,683:
| style="text-align:right" | '''33,853'''
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | P&C
| style="text-align:right" | 206
| style="text-align:right" | 0
Line 7,693:
| style="text-align:right" | 282
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Life
| style="text-align:right" | 26,200
| style="text-align:right" | 1,770
Line 7,703:
| style="text-align:right" | 25,826
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Health
| style="text-align:right" | 7,782
| style="text-align:right" | 400
Line 7,749:
| style="text-align:right" | '''33,253'''
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | P&C
| style="text-align:right" | 282
| style="text-align:right" | 0
Line 7,759:
| style="text-align:right" | 261
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Life
| style="text-align:right" | 25,826
| style="text-align:right" | 1,822
Line 7,769:
| style="text-align:right" | 25,442
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Health
| style="text-align:right" | 7,744
| style="text-align:right" | 377
Line 7,843:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Government Bonds
| style="text-align:right" | 167
| style="text-align:right" | 37%
Line 7,856:
| style="text-align:right" | 2%
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Corporate Bonds and Loans
| style="text-align:right" | 121
| style="text-align:right" | 27%
Line 7,869:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Fixed Income
| style="text-align:right" | 56
| style="text-align:right" | 13%
Line 7,882:
| style="text-align:right" | —
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Asset Backed Securities {{footnote|1=Includes 91% of CLOs.}}
| style="text-align:right" | 25
| style="text-align:right" | 6%
Line 7,895:
| style="text-align:right" | 4%
|-
| class="wt-indent-2" style="text-align:left; padding-left:3em" | Mortgage Loans {{footnote|1=Residential loans (Euro 16 billion), Agency Pools (Euro 8 billion), and Commercial & agricultural loans (Euro 7 billion).}}
| style="text-align:right" | 31
| style="text-align:right" | 7%
Line 8,273:
| style="text-align:right" | 1.3
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Comprehensive Income Related to Invested Assets
| style="text-align:right" | -4.2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Comprehensive Income Related to (re) Insurance Contracts
| style="text-align:right" | 5.4
|-
Line 8,326:
| style="text-align:right" | -6.8
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Comprehensive Income Related to Invested Assets
| style="text-align:right" | -13.1
| style="text-align:right" | -17.3
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Other Comprehensive Income Related to (re) Insurance Contracts
| style="text-align:right" | 5.0
| style="text-align:right" | 10.5
Line 8,475:
| style="text-align:right" | 3.2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Financing Debt Instrument Issued
| style="text-align:right" | 3.2
| style="text-align:right" | 3.2
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Financing Debt Owed to Credit Institutions
| style="text-align:right" | 0.0
| style="text-align:right" | 0.0
Line 8,602:
| style="text-align:right" | 0.4
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Ancillary
| style="text-align:right" | —
| style="text-align:right" | —
Line 8,609:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Subject to Transitional Measures {{footnote|1=Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.}}
| style="text-align:right" | 2.4
| style="text-align:right" | —
Line 8,637:
| style="text-align:right" | 0.8
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Ancillary
| style="text-align:right" | —
| style="text-align:right" | —
Line 8,644:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left; padding-left:1.5em" | Subject to Transitional Measures {{footnote|1=Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.}}
| style="text-align:right" | 4.5
| style="text-align:right" | —
Line 8,737:
| style="text-align:right" | -21.3
|-
| class="wt-indent-4" style="text-align:left; padding-left:7.5em" | Goodwill
| style="text-align:right" | -17.8
|-
| class="wt-indent-4" style="text-align:left; padding-left:7.5em" | others
| style="text-align:right" | -3.5
|-
Line 8,752:
| style="text-align:right" | -9.6
|-
| class="wt-indent-4" style="text-align:left; padding-left:7.5em" | Risk Margin vs Risk Adjustment
| style="text-align:right" | -6.4
|-
| class="wt-indent-4" style="text-align:left; padding-left:7.5em" | BEL adjustment
| style="text-align:right" | -3.2
|-
Retrieved from "https://www.insurerbrain.com/wiki/AXA/2025/FY/Financial_supplement"